{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":20,"description":"Patients who experience CRS/ICANS will receive this treatment\n\nSiltuximab: Siltuximab is administered at the dose of 11mg/kg via intravenous infusion over 1 hour. If no resolution of CRS is achieved then a repeat dose of siltuximab at the dose of 11mg/kg via intravenous infusion over 1 hour will be given.","id":"EG000","otherNumAffected":0,"otherNumAtRisk":20,"seriousNumAffected":0,"seriousNumAtRisk":20,"title":"Siltuximab"}],"frequencyThreshold":"0","timeFrame":"90 days"}